Featured Stories

Though it’s not yet legal federally to add CBD to food and dietary supplements, many U.S. states currently allow it through state-specific legislation.

Dr. Klumpers co-authored the spring 2022 report with Michael Tagen, Ph.D., of Verdient Science LLC, in the British Journal of Pharmacology.

Clinical trials repeatedly demonstrate psilocybin’s promise for treating mood, anxiety, and substance use disorders.

Klumpers, along with Geert Jan Groeneveld and Albert Dahan, intends to gain more insight into the use of medicinal cannabis in the treatment of neuropathic pain.

Dr. MacKay is original editor of Extraction Magazine and is still a contributing author for many journals in cannabis science.

Cannabis-based products, including hemp-derived cannabidiol (CBD), are marketed as improving health, but few regulations exist to ensure product quality.

In The News

Professor of Psychiatry Hugh Garavan and researcher Catherine Orr find that "even small amounts" of marijuana changes teen brains. 

UVM-based Vermont Academic Detailing Program, offered through the Office of Primary Care and Area Health Education Centers Program, launches a session on cannabinoids.

UVM's Drs. Kalev Freeman and Monique McHenry help in bridging the knowledge gap in Cannabis science.

UVM's Dr. Linda Klumpers in a recent Rolling Stone article.

Dr. Monique McHenry was featured in a recent Forbes article.

Dr. Monique McHenry was featured in a POLITICOPRO article.